XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver failure and liver cancer. Chronic necro-inflammation is a critical factor in development of NASH, yet the cellular and molecular mechanisms of immune dysregulation in this disease are poorly understood. Here, using single-cell transcriptomic analysis, we comprehensively profiled the immune composition of the mouse liver during NASH. We identified a significant pathology-associated increase in hepatic conventional dendritic cells (cDCs) and further defined their source as NASH-induced boost in cycling of cDC progenitors in the bone marrow. Analysis of blood and liver from patients on the NAFLD/NASH spectrum showed that type 1 cDCs (cDC1) were more abundant and activated in disease. Sequencing of physically interacting cDC-T cell pairs from liver-draining lymph nodes revealed that cDCs in NASH promote inflammatory T cell reprogramming, previously associated with NASH worsening. Finally, depletion of cDC1 in XCR1 DTA mice or using anti-XCL1-blocking antibody attenuated liver pathology in NASH mouse models. Overall, our study provides a comprehensive characterization of cDC biology in NASH and identifies XCR1+ cDC1 as an important driver of liver pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the peripheral blood frequency of XCR1+ cDC1s has been reported to be greater in patients with MASLD/MASH compared with healthy controls53”
In the citing paper
“On the other hand, a NASH-promoting role of cDC1s was shown in mice by blocking X-C motif chemokine ligand 1 (XCL1), a chemokine with a key role in cDC1 recruitment, or by genetic depletion of cDC1 expressing XCR1, the receptor for XCL1.81”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [81]
In the citing paper
“Thus, the XCL1-XCR1 axis seems to be a key mediator of hepatic cDC1 recruitment in NASH.”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [81]
In the citing paper
“XCR1+ cDC1s promote inflammatory T-cell reprogramming, thereby aggravating NASH in mouse models.85”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [85]
In the citing paper
“In NASH, XCR1 (X–C motif chemokine receptor 1)-expressing cDC1s are found abundantly in both patients with NASH and murine steatohepatitis, and correlate with NASH severity.85”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [85]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
Self-citationBöttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Zhang, Q., He, Y., Luo, N., Patel, S. J., Han, Y., Gao, R., Modak, M., Carotta, S., Haslinger, C., Kind, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.003 · Cited by 1,624
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Research works printed but not linked: 1
- Zang, S. et al. Neutrophils play a crucial role in the early stage of nonalcoholic steatohepatitis via neutrophil elastase in mice. Cell Biochem. Biophys. 73, 479–487 (2015). · DOI
Cited by
Hepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
Dimitrov, D., Türei, D., Garrido-Rodriguez, M., Burmedi, P. L., Nagai, J. S., Boys, C., Ramirez Flores, R. O., Kim, H., Szalai, B., Costa, I. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30755-0 · Cited by 664
The immunological and metabolic landscape in primary and metastatic liver cancer
Li, X., Ramadori, P., Pfister, D., Seehawer, M., Zender, L., & Heikenwalder, M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00383-9 · Cited by 616
Self-citationImmune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Self-citation
Metadata
- Authors
- Deczkowska, A., David, E., Ramadori, P., Pfister, D., Safran, M., Li, B., Giladi, A., Jaitin, D. A., Barboy, O., Cohen, M., Yofe, I., Gur, C., Shlomi-Loubaton, S., Henri, S., Suhail, Y., Qiu, M., Kam, S., Hermon, H., Lahat, E., Ben Yakov, G., Cohen-Ezra, O., Davidov, Y., Likhter, M., Goitein, D., Roth, S., Weber, A., Malissen, B., Weiner, A., Ben-Ari, Z., Heikenwälder, M., Elinav, E., & Amit, I.
- Affiliations
- Institut Pasteur (FR)
- Weizmann Institute of Science (IL)
- German Cancer Research Center (DE)
- Sheba Medical Center (IL)
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Centre National de la Recherche Scientifique (FR)
- University Hospital Heidelberg (DE)
- University Hospital Zurich (CH)
- ORCID
- Deczkowska, Aleksandra
- David, Eyal
- Ramadori, Pierluigi
- Pfister, Dominik
- Safran, Michal
- Giladi, Amir
- Jaitin, Diego Adhemar
- Barboy, Oren
- Cohen, Merav
- Yofe, Ido
- Gur, Chamutal
- Henri, Sandrine
- Lahat, Eylon
- Davidov, Yana
- Likhter, Mariya
- Goitein, David
- Roth, Susanne
- Weber, Achim
- Malissen, Bernard
- Weiner, Assaf
- Heikenwälder, Mathias
- Elinav, Eran
- Amit, Ido
- Venue
- Nature Medicine
- Published
- 2021-05-20
- Volume
- 27
- Issue
- 6
- Pages
- 1043-1054
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W3160603270
- Cited by
- 197
- References
- 67
- Citations by year
- 2026: 19 · 2025: 42 · 2024: 47 · 2023: 37 · 2022: 40 · 2021: 11
- FWCI
- 24.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-01-12)
- Open access
- green
- hal.science
- Licence
- other-oa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL AMU (submittedVersion, other-oa)
- Funders
- Howard Hughes Medical Institute
- Wellcome Trust
- Agence Nationale de la Recherche (ANR-10-INBS-0007)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, myeloid dendritic cells, cDC1, XCR1, XCL1, bone marrow, T cell reprogramming, single-cell transcriptomics, liver pathology
- MeSH terms
- Animals, Bone Marrow Cells, Dendritic Cells, Disease Models, Animal, Fatty Liver, Female, Humans, Liver, Lymph Nodes, Male, T-Lymphocytes, Receptors, Chemokine, Mice, Diet, High-Fat, Cellular Reprogramming, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. https://app.cochat.ai/papers/10.1038/s41591-021-01344-3
- The paper
- Deczkowska, A., David, E., Ramadori, P., Pfister, D., Safran, M., Li, B., Giladi, A., Jaitin, D. A., Barboy, O., Cohen, M., Yofe, I., Gur, C., Shlomi-Loubaton, S., Henri, S., Suhail, Y., Qiu, M., Kam, S., Hermon, H., Lahat, E., . . . Amit, I. (2021). XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. Nature Medicine. https://doi.org/10.1038/s41591-021-01344-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.